Received Jul 7, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| TDAP | TDAP (BOOSTRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
TDAP that was administered unfortunately it was expired; This non-serious case was reported by a consumer via interactive digital media and described the occurrence of expired vaccine used in a patient who received DTPa (Reduced antigen) (Boostrix) for prophylaxis. On an unknown date, the patient received Boostrix. On an unknown date, an unknown time after receiving Boostrix, the patient experienced expired vaccine used (Verbatim: TDAP that was administered unfortunately it was expired). The outcome of the expired vaccine used was not applicable. Additional Information: GSK Receipt Date: 26-JUN-2025 This case was reported by a patient via (chatbot) interactive digital media. The patient had GSK product TDAP that was administered. Unfortunately it was expired which was Expired vaccine administered.